BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,063 filers reported holding BAXTER INTL INC in Q3 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,438,012 | -20.5% | 38,103 | -4.0% | 0.01% | -12.5% |
| Q2 2023 | $1,808,232 | +2.1% | 39,689 | -9.1% | 0.01% | 0.0% |
| Q1 2023 | $1,770,848 | -20.9% | 43,660 | -0.7% | 0.01% | -27.3% |
| Q4 2022 | $2,240,082 | -10.6% | 43,949 | -5.6% | 0.01% | -15.4% |
| Q3 2022 | $2,507,000 | -16.2% | 46,552 | +0.0% | 0.01% | -13.3% |
| Q2 2022 | $2,990,000 | -21.1% | 46,545 | -4.7% | 0.02% | -6.2% |
| Q1 2022 | $3,789,000 | -12.3% | 48,866 | -2.9% | 0.02% | -5.9% |
| Q4 2021 | $4,319,000 | +8.1% | 50,312 | +1.3% | 0.02% | 0.0% |
| Q3 2021 | $3,995,000 | +0.6% | 49,670 | +0.6% | 0.02% | 0.0% |
| Q2 2021 | $3,973,000 | -52.9% | 49,358 | -50.6% | 0.02% | -15.0% |
| Q1 2021 | $8,430,000 | +104.9% | 99,950 | +94.9% | 0.02% | 0.0% |
| Q4 2020 | $4,115,000 | -12.6% | 51,281 | -12.4% | 0.02% | -20.0% |
| Q3 2020 | $4,709,000 | -6.0% | 58,549 | +0.7% | 0.02% | -13.8% |
| Q2 2020 | $5,007,000 | +5.3% | 58,151 | -0.7% | 0.03% | -9.4% |
| Q1 2020 | $4,754,000 | -6.5% | 58,548 | -3.7% | 0.03% | +18.5% |
| Q4 2019 | $5,084,000 | -5.4% | 60,803 | -1.1% | 0.03% | -12.9% |
| Q3 2019 | $5,377,000 | +3.1% | 61,470 | -3.5% | 0.03% | +3.3% |
| Q2 2019 | $5,215,000 | -1.6% | 63,672 | -2.3% | 0.03% | -6.2% |
| Q1 2019 | $5,300,000 | +20.8% | 65,177 | -2.2% | 0.03% | +10.3% |
| Q4 2018 | $4,387,000 | -19.3% | 66,658 | -5.5% | 0.03% | -3.3% |
| Q3 2018 | $5,435,000 | -1.9% | 70,503 | -6.1% | 0.03% | -6.2% |
| Q2 2018 | $5,543,000 | +11.9% | 75,063 | -1.4% | 0.03% | +10.3% |
| Q1 2018 | $4,953,000 | +4.7% | 76,160 | +4.1% | 0.03% | +7.4% |
| Q4 2017 | $4,730,000 | -9.9% | 73,182 | -12.5% | 0.03% | -12.9% |
| Q3 2017 | $5,250,000 | +2.3% | 83,666 | -1.3% | 0.03% | 0.0% |
| Q2 2017 | $5,131,000 | -3.4% | 84,760 | -17.3% | 0.03% | -3.1% |
| Q1 2017 | $5,313,000 | +5.8% | 102,445 | -9.5% | 0.03% | +3.2% |
| Q4 2016 | $5,020,000 | -21.8% | 113,224 | -16.1% | 0.03% | -22.5% |
| Q3 2016 | $6,422,000 | +25.8% | 134,926 | +19.5% | 0.04% | +21.2% |
| Q2 2016 | $5,105,000 | -19.6% | 112,899 | -26.9% | 0.03% | -21.4% |
| Q1 2016 | $6,346,000 | -6.9% | 154,470 | -13.5% | 0.04% | -8.7% |
| Q4 2015 | $6,816,000 | +50.2% | 178,654 | +29.4% | 0.05% | +43.8% |
| Q3 2015 | $4,537,000 | -53.8% | 138,107 | -1.7% | 0.03% | -50.8% |
| Q2 2015 | $9,824,000 | -7.6% | 140,483 | -9.5% | 0.06% | -5.8% |
| Q1 2015 | $10,630,000 | -9.3% | 155,175 | -3.0% | 0.07% | -10.4% |
| Q4 2014 | $11,726,000 | -2.8% | 159,993 | -4.8% | 0.08% | -7.2% |
| Q3 2014 | $12,061,000 | -5.1% | 168,051 | -4.4% | 0.08% | -1.2% |
| Q2 2014 | $12,707,000 | -5.1% | 175,752 | -3.4% | 0.08% | -19.2% |
| Q1 2014 | $13,390,000 | +2.2% | 181,981 | -3.4% | 0.10% | +22.4% |
| Q4 2013 | $13,102,000 | -9.1% | 188,386 | -14.2% | 0.08% | -14.1% |
| Q3 2013 | $14,418,000 | -89.3% | 219,481 | -88.7% | 0.10% | -80.1% |
| Q2 2013 | $134,589,000 | +15.5% | 1,941,541 | +21.0% | 0.50% | +15.3% |
| Q1 2013 | $116,569,000 | +34.0% | 1,604,768 | +23.0% | 0.43% | +24.2% |
| Q4 2012 | $87,000,000 | – | 1,305,133 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |